Age Effects on Liver Inflammation and Injury
年龄对肝脏炎症和损伤的影响
基本信息
- 批准号:7071795
- 负责人:
- 金额:$ 29.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-06-01 至 2010-05-31
- 项目状态:已结题
- 来源:
- 关键词:Kupffer&aposs cellSDS polyacrylamide gel electrophoresisage differenceanimal old ageapoptosiscellular pathologycytoprotectionenzyme linked immunosorbent assaygel mobility shift assayheat shock proteinshelper T lymphocyteimmunoprecipitationinfant animalinflammationischemialaboratory mouseleukocyte activation /transformationliver cellsliver disordernuclear factor kappa betaoxidative stressposttranslational modificationsproteomicsreperfusionsmall interfering RNAwestern blottings
项目摘要
DESCRIPTION (provided by the applicant): Hepatic injury is a primary cause of liver dysfunction in both pediatric and adult patients. Our preliminary studies using an established model of murine hepatic I/R indicate that mature mice (12-13 months of age) have significantly greater liver injury after I/R than do young mice (6-8 weeks of age). These findings are consistent with clinical studies of trauma patients which suggest that pediatric patients have a far lower incidence of multiple organ dysfunction syndrome than do adult patients. The long-term goal of this proposal is to determine the molecular and cellular mechanisms that differentiate young and mature mice in their response to hepatic I/R. Aim 1 will test the hypothesis that the transcription factor, NF-KB, is selectively depressed in hepatocytes of mature mice, leading to increased cell death and organ injury. We show that NF-KappaB activation is decreased in whole livers from mature mice, but that proinflammatory cytokine production is unaltered, suggesting that Kupffer cell activation of NF-KappaB is unaltered with age. Aim 2 will test the hypothesis that reduced hepatic expression of HSP70 in mature mice leads to increased oxidative tissue injury and hepatocyte cell death contributing to augmented I/R injury. We provide evidence that HSP70 protein expression is reduced in livers from mature mice and that this is associated with increased hepatocellular injury of both necrotic and apoptotic mechanisms. Aim 3 will test the hypothesis that CD4 lymphocytes serve to regulate hepatic I/R injury and that in mature mice altered function of CD4 lymphocytes contributes to augmented liver injury. Our preliminary data demonstrates that CD4-knockout mice have increased liver injury after I/R in a pattern that is identical to that observed in mature mice. We also show significant differences in the phenotypes of liver-resident lymphocytes between young and mature mice. Aim 4 will test the hypothesis that there are a number of cell-specific alterations in the proteomes of liver cells between young and mature mice and that these changes contribute to the divergent responses to I/R injury in these age populations. We will employ proteomics to determine the subcellular proteomes of Kupffer cells, hepatocytes, sinusoidal endothelial cells, and liver-resident lymphocytes before and after I/R to identify age-related alterations. These studies will advance our understanding of the age-dependent mechanisms that differentiate the hepatic inflammatory response of adult and pediatric patient populations to acute liver injury.
描述(由申请人提供):肝损伤是儿童和成人患者肝功能障碍的主要原因。我们使用已建立的小鼠肝脏I/R模型进行的初步研究表明,成熟小鼠(12-13月龄)在I/R后的肝损伤明显大于年轻小鼠(6-8周龄)。这些发现与创伤患者的临床研究一致,表明儿科患者的多器官功能障碍综合征发生率远低于成人患者。本研究的长期目标是确定年轻和成熟小鼠对肝脏I/R反应的分子和细胞机制。目的1将验证成熟小鼠肝细胞中转录因子NF-KB被选择性抑制,导致细胞死亡和器官损伤增加的假设。我们发现,在成熟小鼠的全肝中,NF-KappaB的活化降低,但促炎细胞因子的产生没有改变,这表明NF-KappaB的库普弗细胞活化不会随着年龄的增长而改变。目的2将验证成熟小鼠肝脏HSP70表达降低导致氧化组织损伤和肝细胞死亡增加,从而增强I/R损伤的假设。我们提供的证据表明,成熟小鼠肝脏中HSP70蛋白表达降低,这与坏死和凋亡机制的肝细胞损伤增加有关。目的3将验证CD4淋巴细胞调节肝脏I/R损伤的假设,以及成熟小鼠CD4淋巴细胞功能改变导致肝损伤增强的假设。我们的初步数据表明,cd4敲除小鼠在I/R后的肝损伤增加,其模式与在成熟小鼠中观察到的相同。我们还发现,在年轻小鼠和成熟小鼠之间,肝脏驻留淋巴细胞的表型存在显著差异。目的4将验证一个假设,即在年轻和成熟小鼠的肝细胞蛋白质组中存在许多细胞特异性改变,这些变化有助于这些年龄人群对I/R损伤的不同反应。我们将使用蛋白质组学来确定I/R前后Kupffer细胞、肝细胞、窦内皮细胞和肝驻留淋巴细胞的亚细胞蛋白质组,以确定年龄相关的改变。这些研究将促进我们对年龄依赖机制的理解,这些机制区分了成人和儿科患者群体对急性肝损伤的肝脏炎症反应。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alex B. Lentsch其他文献
線維化を伴う肝臓は急性肝障害後に肝再生・修復が促進される
在纤维化的肝脏中,急性肝损伤后肝脏再生和修复得到促进。
- DOI:
- 发表时间:
2020 - 期刊:
- 影响因子:0
- 作者:
小西孝宜;吉富秀幸;古川勝規;高屋敷吏;久保木知;高野重紹;鈴木大亮;酒井望;賀川真吾;三島敬;中台英里;Alex B. Lentsch;大塚将之 - 通讯作者:
大塚将之
CXC Chemokine Receptor 1 Mediates Fibrosis in Carbon Tetrachloride Model of Chronic Liver Injury
- DOI:
10.1016/j.jamcollsurg.2014.07.047 - 发表时间:
2014-09-01 - 期刊:
- 影响因子:
- 作者:
Christopher M. Freeman;Gregory C. Wilson;Rebecca M. Schuster;Hiroyuki Nojima;Alex B. Lentsch - 通讯作者:
Alex B. Lentsch
Roles of NF-kappaB and STAT3 in CXC chemokine–mediated hepatocyte proliferation and cell death
- DOI:
10.1016/j.jamcollsurg.2009.06.141 - 发表时间:
2009-09-01 - 期刊:
- 影响因子:
- 作者:
Callisia N. Clarke;S. Kuboki;Amit Tevar;Alex B. Lentsch;Michael Edwards - 通讯作者:
Michael Edwards
Colchicine disrupts vectorial secretion of IL-8 in Caco-2 cells
- DOI:
10.1016/j.jamcollsurg.2011.06.128 - 发表时间:
2011-09-01 - 期刊:
- 影响因子:
- 作者:
Dennis I. Sonnier;Stephanie R. Bailey;Alex B. Lentsch;Timothy A. Pritts - 通讯作者:
Timothy A. Pritts
How does liver recover and regenerate after hepatic ischemia reperfusion injury? ~Contribution of YAP and TAZ to liver repair~
肝脏缺血再灌注损伤后肝脏如何恢复和再生?~YAP和TAZ对肝脏修复的贡献~
- DOI:
- 发表时间:
2021 - 期刊:
- 影响因子:0
- 作者:
小西孝宜;吉富秀幸;古川勝規;高屋敷吏;久保木知;高野重紹;鈴木大亮;酒井望;賀川真吾;三島敬;中台英里;Alex B. Lentsch;大塚将之 - 通讯作者:
大塚将之
Alex B. Lentsch的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alex B. Lentsch', 18)}}的其他基金
Hepatic Ischemia/Reperfusion-Induced Lung Injury
肝缺血/再灌注引起的肺损伤
- 批准号:
6584706 - 财政年份:2002
- 资助金额:
$ 29.98万 - 项目类别:
相似海外基金
Determining how the G1/S cell cycle transition regulates the homeostasis of adult intestinal stem cells
确定 G1/S 细胞周期转变如何调节成体肠道干细胞的稳态
- 批准号:
9607770 - 财政年份:2018
- 资助金额:
$ 29.98万 - 项目类别:
Determining how the G1/S cell cycle transition regulates the homeostasis of adult intestinal stem cells
确定 G1/S 细胞周期转变如何调节成体肠道干细胞的稳态
- 批准号:
9899107 - 财政年份:2018
- 资助金额:
$ 29.98万 - 项目类别:
PROTEOLYSIS AND MAMMALIAN GL/S CELL CYCLE TRANSITION
蛋白质水解和哺乳动物 GL/S 细胞周期转变
- 批准号:
2871922 - 财政年份:1998
- 资助金额:
$ 29.98万 - 项目类别:
PROTEOLYSIS AND MAMMALIAN GL/S CELL CYCLE TRANSITION
蛋白质水解和哺乳动物 GL/S 细胞周期转变
- 批准号:
6800864 - 财政年份:1998
- 资助金额:
$ 29.98万 - 项目类别:
PROTEOLYSIS AND MAMMALIAN GL/S CELL CYCLE TRANSITION
蛋白质水解和哺乳动物 GL/S 细胞周期转变
- 批准号:
6350210 - 财政年份:1998
- 资助金额:
$ 29.98万 - 项目类别:
PROTEOLYSIS AND MAMMALIAN GL/S CELL CYCLE TRANSITION
蛋白质水解和哺乳动物 GL/S 细胞周期转变
- 批准号:
2628102 - 财政年份:1998
- 资助金额:
$ 29.98万 - 项目类别:
PROTEOLYSIS AND MAMMALIAN GL/S CELL CYCLE TRANSITION
蛋白质水解和哺乳动物 GL/S 细胞周期转变
- 批准号:
6150049 - 财政年份:1998
- 资助金额:
$ 29.98万 - 项目类别:
PROTEOLYSIS AND MAMMALIAN GL/S CELL CYCLE TRANSITION
蛋白质水解和哺乳动物 GL/S 细胞周期转变
- 批准号:
6497689 - 财政年份:1998
- 资助金额:
$ 29.98万 - 项目类别:
G1/S CELL CYCLE CONTROL IN HEMATOPOIETIC CELLS
造血细胞中的 G1/S 细胞周期控制
- 批准号:
2143404 - 财政年份:1991
- 资助金额:
$ 29.98万 - 项目类别:
G1/S CELL CYCLE CONTROL IN HUMAN HEMATOPOIETIC CELLS
人类造血细胞中的 G1/S 细胞周期控制
- 批准号:
3245433 - 财政年份:1991
- 资助金额:
$ 29.98万 - 项目类别:














{{item.name}}会员




